15-91002143-G-A
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_018668.5(VPS33B):c.1312C>T(p.Arg438*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000805 in 1,614,078 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_018668.5 stop_gained
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_018668.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| VPS33B | NM_018668.5 | MANE Select | c.1312C>T | p.Arg438* | stop_gained | Exon 18 of 23 | NP_061138.3 | ||
| VPS33B | NM_001289148.1 | c.1231C>T | p.Arg411* | stop_gained | Exon 17 of 22 | NP_001276077.1 | |||
| VPS33B | NM_001289149.1 | c.1039C>T | p.Arg347* | stop_gained | Exon 17 of 22 | NP_001276078.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| VPS33B | ENST00000333371.8 | TSL:1 MANE Select | c.1312C>T | p.Arg438* | stop_gained | Exon 18 of 23 | ENSP00000327650.4 | ||
| ENSG00000284946 | ENST00000643536.1 | n.1312C>T | non_coding_transcript_exon | Exon 18 of 35 | ENSP00000494429.1 | ||||
| VPS33B | ENST00000535906.1 | TSL:2 | c.1231C>T | p.Arg411* | stop_gained | Exon 17 of 22 | ENSP00000444053.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152216Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000119 AC: 3AN: 251346 AF XY: 0.0000221 show subpopulations
GnomAD4 exome AF: 0.00000821 AC: 12AN: 1461862Hom.: 0 Cov.: 32 AF XY: 0.0000151 AC XY: 11AN XY: 727226 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152216Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74358 show subpopulations
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25525159, 17994566, 16896922, 23918659, 11668108, 8151641, 15052268)
VPS33B: PVS1, PM2, PM3
VPS33B-related disorder Pathogenic:1
The VPS33B c.1312C>T variant is predicted to result in premature protein termination (p.Arg438*). This variant was reported in the homozygous state in multiple unrelated consanguineous individuals with arthrogryposis, renal dysfunction and cholestasis (Gissen et al. 2004. PubMed ID: 15052268). This variant is reported in 0.0033% of alleles in individuals of South Asian descent in gnomAD. Nonsense variants in VPS33B are expected to be pathogenic. This variant is interpreted as pathogenic.
Arthrogryposis, renal dysfunction, and cholestasis 1;C5774200:Keratoderma-ichthyosis-deafness syndrome, autosomal recessive;C5774311:Cholestasis, progressive familial intrahepatic, 12 Pathogenic:1
Arthrogryposis, renal dysfunction, and cholestasis 1 Pathogenic:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at